Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 14-Mar-23 5:16 PM View:  | Novavax, Inc. (NVAX) | 10-Mar-23 | Payment of Exercise | 2,432 | $6.52 | $15,856.60 | (12%) 20.77K to 18.34K | |
| 14-Mar-23 5:16 PM View: | Novavax, Inc. (NVAX) | 10-Mar-23 | Option Exercise | 6,298 | $6.52 | $41,063.00 | 47% 13.47K to 19.77K | |
| 14-Mar-23 5:16 PM View: | Novavax, Inc. (NVAX) | 10-Mar-23 | Purchase | 1,000 | $6.50 | $6,500.00 | 5% 19.77K to 20.77K | |
| 14-Mar-23 5:16 PM View: | Novavax, Inc. (NVAX) | 07-Mar-23 | Purchase | 2,000 | $7.04 | $14,088.00 | 17% 11.47K to 13.47K | |
| 14-Mar-23 5:16 PM View: | Novavax, Inc. (NVAX) | 06-Mar-23 | Private Purchase | 3,000 | $7.48 | $22,453.50 | 35% 8.47K to 11.47K | |
| 16-Dec-22 5:01 PM View: | Novavax, Inc. (NVAX) | 14-Dec-22 | Payment of Exercise | 1,033 | $17.23 | $17,798.60 | (11%) 9.04K to 8.01K | |
| 16-Dec-22 5:01 PM View: | Novavax, Inc. (NVAX) | 14-Dec-22 | Option Exercise | 3,100 | -- | -- | 52% 5.94K to 9.04K | |
| 16-Dec-21 5:15 PM View: | Novavax, Inc. (NVAX) | 15-Dec-21 | Option Exercise | 1,686 | $34.82 | $58,714.40 | 30% 5.66K to 7.35K | |
| 16-Dec-21 5:15 PM View: | Novavax, Inc. (NVAX) | 15-Dec-21 | Market Option Sale (Planned) | 1,686 | $174.13 | $293,584.00 | (23%) 7.35K to 5.66K | |
| 16-Dec-21 5:15 PM View: | Novavax, Inc. (NVAX) | 14-Dec-21 | Payment of Exercise | 1,498 | $168.43 | $252,308.00 | (21%) 7.16K to 5.66K | |
| 16-Dec-21 5:15 PM View: | Novavax, Inc. (NVAX) | 14-Dec-21 | Option Exercise | 3,100 | -- | -- | 76% 4.06K to 7.16K | |
| 09-Dec-21 5:20 PM View: | Novavax, Inc. (NVAX) | 07-Dec-21 | Option Exercise | 8,250 | $19.08 | $157,410.00 | 203% 4.06K to 12.31K | |
| 09-Dec-21 5:20 PM View: | Novavax, Inc. (NVAX) | 07-Dec-21 | Market Option Sale (Planned) | 8,250 | $170.14 | $1,403,630.00 | (67%) 12.31K to 4.06K | |
| 02-Dec-21 4:13 PM View: | Novavax, Inc. (NVAX) | 30-Nov-21 | Option Exercise | 8,250 | $19.08 | $157,410.00 | 174% 4.75K to 13.0K | |
| 02-Dec-21 4:13 PM View: | Novavax, Inc. (NVAX) | 30-Nov-21 | Market Option Sale (Planned) | 8,250 | $203.20 | $1,676,390.00 | (63%) 13.0K to 4.75K | |
| 02-Dec-21 4:13 PM View: | Novavax, Inc. (NVAX) | 30-Nov-21 | Market Sale (Planned) | 692 | $203.20 | $140,613.00 | (15%) 4.75K to 4.06K | |
| 30-Nov-21 5:06 PM View: | Novavax, Inc. (NVAX) | 26-Nov-21 | Disposition | 38 | $217.97 | $8,282.86 | (< 1%) 7.52K to 7.48K | |
| 30-Nov-21 5:06 PM View: | Novavax, Inc. (NVAX) | 26-Nov-21 | Payment of Exercise | 647 | $217.97 | $141,027.00 | (9%) 7.48K to 6.84K | |
| 30-Nov-21 5:06 PM View: | Novavax, Inc. (NVAX) | 26-Nov-21 | Option Exercise | 3,460 | $5.95 | $20,587.00 | 85% 4.06K to 7.52K | |
| 30-Nov-21 5:06 PM View: | Novavax, Inc. (NVAX) | 26-Nov-21 | Market Option Sale (Planned) | 2,083 | $218.07 | $454,247.00 | (30%) 6.84K to 4.75K | |
| 24-Nov-21 5:21 PM View: | Novavax, Inc. (NVAX) | 23-Nov-21 | Option Exercise | 8,250 | $19.08 | $157,410.00 | 203% 4.06K to 12.31K | |
| 24-Nov-21 5:21 PM View: | Novavax, Inc. (NVAX) | 23-Nov-21 | Market Option Sale (Planned) | 8,250 | $199.51 | $1,645,910.00 | (67%) 12.31K to 4.06K | |
| 17-Nov-21 5:25 PM View: | Novavax, Inc. (NVAX) | 16-Nov-21 | Option Exercise | 8,250 | $19.08 | $157,410.00 | 203% 4.06K to 12.31K | |
| 17-Nov-21 5:25 PM View: | Novavax, Inc. (NVAX) | 16-Nov-21 | Market Option Sale (Planned) | 8,250 | $169.48 | $1,398,180.00 | (67%) 12.31K to 4.06K | |
| 17-Nov-21 5:25 PM View: | Novavax, Inc. (NVAX) | 15-Nov-21 | Option Exercise | 1,183 | $37.90 | $44,831.60 | 29% 4.06K to 5.24K | |
| 17-Nov-21 5:25 PM View: | Novavax, Inc. (NVAX) | 15-Nov-21 | Market Option Sale (Planned) | 1,183 | $172.02 | $203,496.00 | (23%) 5.24K to 4.06K | |
| 12-Nov-21 5:02 PM View: | Novavax, Inc. (NVAX) | 09-Nov-21 | Option Exercise | 8,250 | $19.08 | $157,410.00 | 203% 4.06K to 12.31K | |
| 12-Nov-21 5:02 PM View: | Novavax, Inc. (NVAX) | 09-Nov-21 | Market Option Sale (Planned) | 8,250 | $167.54 | $1,382,160.00 | (67%) 12.31K to 4.06K | |
| 04-Nov-21 5:22 PM View: | Novavax, Inc. (NVAX) | 02-Nov-21 | Option Exercise | 8,250 | $19.08 | $157,410.00 | 203% 4.06K to 12.31K | |
| 04-Nov-21 5:22 PM View: | Novavax, Inc. (NVAX) | 02-Nov-21 | Market Option Sale (Planned) | 8,250 | $183.82 | $1,516,550.00 | (67%) 12.31K to 4.06K | |
| 02-Nov-21 7:02 PM View: | Novavax, Inc. (NVAX) | 29-Oct-21 | Market Sale (Planned) | 680 | $148.34 | $100,871.00 | (14%) 4.74K to 4.06K | (16%) |
| 28-Oct-21 5:09 PM View: | Novavax, Inc. (NVAX) | 26-Oct-21 | Disposition | 61 | $134.99 | $8,234.39 | (< 1%) 15.77K to 15.71K | |
| 28-Oct-21 5:09 PM View: | Novavax, Inc. (NVAX) | 26-Oct-21 | Payment of Exercise | 637 | $134.99 | $85,988.60 | (4%) 15.71K to 15.07K | |
| 28-Oct-21 5:09 PM View: | Novavax, Inc. (NVAX) | 26-Oct-21 | Option Exercise | 11,712 | $15.20 | $178,009.00 | 288% 4.06K to 15.77K | |
| 28-Oct-21 5:09 PM View: | Novavax, Inc. (NVAX) | 26-Oct-21 | Market Option Sale (Planned) | 10,334 | $132.73 | $1,371,670.00 | (69%) 15.07K to 4.74K | |
| 21-Oct-21 5:08 PM View: | Novavax, Inc. (NVAX) | 19-Oct-21 | Option Exercise | 8,250 | $19.08 | $157,410.00 | 203% 4.06K to 12.31K | |
| 21-Oct-21 5:08 PM View: | Novavax, Inc. (NVAX) | 19-Oct-21 | Market Option Sale (Planned) | 8,250 | $165.14 | $1,362,430.00 | (67%) 12.31K to 4.06K | |
| 19-Oct-21 5:04 PM View: | Novavax, Inc. (NVAX) | 15-Oct-21 | Option Exercise | 1,183 | $37.90 | $44,831.60 | 29% 4.06K to 5.24K | |
| 19-Oct-21 5:04 PM View: | Novavax, Inc. (NVAX) | 15-Oct-21 | Market Option Sale (Planned) | 1,183 | $170.00 | $201,110.00 | (23%) 5.24K to 4.06K | |
| 14-Oct-21 5:16 PM View: | Novavax, Inc. (NVAX) | 12-Oct-21 | Option Exercise | 8,250 | $19.08 | $157,410.00 | 203% 4.06K to 12.31K | |
| 14-Oct-21 5:16 PM View: | Novavax, Inc. (NVAX) | 12-Oct-21 | Market Option Sale (Planned) | 8,250 | $163.18 | $1,346,220.00 | (67%) 12.31K to 4.06K | |
| 07-Oct-21 5:18 PM View: | Novavax, Inc. (NVAX) | 05-Oct-21 | Option Exercise | 8,250 | $19.08 | $157,410.00 | 203% 4.06K to 12.31K | |
| 07-Oct-21 5:18 PM View: | Novavax, Inc. (NVAX) | 05-Oct-21 | Market Option Sale (Planned) | 8,250 | $174.41 | $1,438,900.00 | (67%) 12.31K to 4.06K | |
| 01-Oct-21 5:58 PM View: | Novavax, Inc. (NVAX) | 30-Sep-21 | Market Sale (Planned) | 693 | $207.25 | $143,622.00 | (15%) 4.75K to 4.06K | (< 1%) |
| 29-Sep-21 5:08 PM View: | Novavax, Inc. (NVAX) | 27-Sep-21 | Disposition | 36 | $231.04 | $8,317.44 | (< 1%) 7.52K to 7.49K | |
| 29-Sep-21 5:08 PM View: | Novavax, Inc. (NVAX) | 27-Sep-21 | Payment of Exercise | 648 | $231.04 | $149,714.00 | (9%) 7.49K to 6.84K | |
| 29-Sep-21 5:08 PM View: | Novavax, Inc. (NVAX) | 27-Sep-21 | Option Exercise | 3,460 | $5.95 | $20,587.00 | 85% 4.06K to 7.52K | |
| 29-Sep-21 5:08 PM View: | Novavax, Inc. (NVAX) | 27-Sep-21 | Market Option Sale (Planned) | 2,083 | $234.43 | $488,315.00 | (30%) 6.84K to 4.75K | |
| 30-Aug-21 6:16 PM View: | Novavax, Inc. (NVAX) | 26-Aug-21 | Disposition | 72 | $230.34 | $16,584.50 | (< 1%) 10.98K to 10.91K | |
| 30-Aug-21 6:16 PM View: | Novavax, Inc. (NVAX) | 26-Aug-21 | Payment of Exercise | 1,296 | $230.34 | $298,521.00 | (12%) 10.91K to 9.61K |